Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal women

To study the bioavailability of dehydroepiandrosterone (DHEA) administered by the oral and percutaneous routes, three groups of 12 postmenopausal women aged 60–70 years received two capsules of 50 mg of DHEA orally before breakfast daily for 14 days or applied 4 g of a 10% DHEA cream or gel at the s...

Ausführliche Beschreibung